
|Articles|April 26, 2016
Incorporating Emerging Innovation in Hemophilia A and B: Tailoring Prophylaxis and Management Strategies in the Managed Care Environment
Advertisement
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
2
52-Week VERIFY Data Show Rusfertide Brings Sustained Responses in PV
3
Once-Monthly Maridebart Cafraglutide Shows Up to 16% Weight Loss
4
As Milestone Nears, an Early Investigator Reflects on Lessons of Imatinib
5













































